Narrow-moat-rated Repligen is a leading provider of bioprocessing solutions for companies that manufacture biologic drugs. Its business lines include advanced filtration and fluid management systems ...

Wall Street is pulling further from its record after reports on Friday showed worries about President Donald Trump's policies may be hitting the U.S. economy.

TV's merger with Hulu + Live TV offers a promising future. Find out why FUBO stock could benefit from Disney's marketing ...

Meanwhile, Ambarella is also going to announce its latest results (for its fiscal 2025 fourth quarter) after the market ...

Our fair value estimate for Inghams is AUD 3.70 per share. This implies a fiscal 2024 enterprise value/EBITDA of 4, a P/E ratio of 12, and fully franked dividend yield of 6%. Our DCF valuation assumes ...

SPRINGFIELD — An improved revenue forecast is helping ease pressure on state finances as Gov. JB Pritzker calls for tightened spending to balance the budget without tax increases on everyday ...

File-sharing company Dropbox Inc. delivered fourth-quarter earnings and revenue that topped Wall Street’s estimates, but its ...

The oncology testing specialist reported strong top-line growth, but also rising costs and ongoing net losses.

The toy company is looking to “diversify our manufacturing footprint to create optionality as we navigate the trade ...

For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...

Walmart on Thursday (Feb. 20) reported fiscal fourth quarter revenue of $180.55 billion, up 4.1% compared with the same ...